分子神经变性 SCIE

期刊简介预计审稿时间： 较慢,6-12周

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

Molecular Neurodegeneration 是一本开放获取、同行评审的期刊，涵盖了分子和细胞层面神经退行性疾病研究的各个方面。

神经退行性疾病统称由神经退行性疾病引起的神经系统疾病，包括但不限于阿尔茨海默病、帕金森病、亨廷顿病和朊病毒病。这些疾病通常与衰老有关，并表现出不同程度的痴呆症，随着人类寿命的延长和老龄化人口的增加，它们已成为一个重大的公共卫生问题。这些神经退行性疾病发病机制背后的分子和细胞机制的最新进展使人们能够更好地了解疾病机制。

《Molecular Neurodegeneration》(分子神经变性)编辑部通讯方式为BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。